Year |
Citation |
Score |
2009 |
Wright ME, Peters U, Gunter MJ, Moore SC, Lawson KA, Yeager M, Weinstein SJ, Snyder K, Virtamo J, Albanes D. Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk. Cancer Research. 69: 1429-38. PMID 19190344 DOI: 10.1158/0008-5472.Can-08-2343 |
0.358 |
|
2008 |
Yu W, Jia L, Wang P, Lawson KA, Simmons-Menchaca M, Park SK, Sun L, Sanders BG, Kline K. In vitro and in vivo evaluation of anticancer actions of natural and synthetic vitamin E forms. Molecular Nutrition & Food Research. 52: 447-56. PMID 18381678 DOI: 10.1002/Mnfr.200700254 |
0.687 |
|
2007 |
Kline K, Lawson KA, Yu W, Sanders BG. Vitamin E and cancer. Vitamins and Hormones. 76: 435-61. PMID 17628185 DOI: 10.1016/S0083-6729(07)76017-X |
0.664 |
|
2007 |
Weinstein SJ, Wright ME, Lawson KA, Snyder K, Männistö S, Taylor PR, Virtamo J, Albanes D. Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1253-9. PMID 17548693 DOI: 10.1158/1055-9965.Epi-06-1084 |
0.367 |
|
2007 |
Wright ME, Weinstein SJ, Lawson KA, Albanes D, Subar AF, Dixon LB, Mouw T, Schatzkin A, Leitzmann MF. Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1128-35. PMID 17548674 DOI: 10.1158/1055-9965.Epi-06-1071 |
0.341 |
|
2006 |
Wright ME, Lawson KA, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, Albanes D. Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. The American Journal of Clinical Nutrition. 84: 1200-7. PMID 17093175 DOI: 10.1093/Ajcn/84.5.1200 |
0.359 |
|
2004 |
Anderson K, Lawson KA, Simmons-Menchaca M, Sun L, Sanders BG, Kline K. Alpha-TEA plus cisplatin reduces human cisplatin-resistant ovarian cancer cell tumor burden and metastasis. Experimental Biology and Medicine (Maywood, N.J.). 229: 1169-76. PMID 15564444 DOI: 10.1177/153537020422901112 |
0.632 |
|
2004 |
Lawson KA, Anderson K, Simmons-Menchaca M, Atkinson J, Sun L, Sanders BG, Kline K. Comparison of vitamin E derivatives alpha-TEA and VES in reduction of mouse mammary tumor burden and metastasis. Experimental Biology and Medicine (Maywood, N.J.). 229: 954-63. PMID 15388892 DOI: 10.1177/153537020422900913 |
0.639 |
|
2004 |
Zhang S, Lawson KA, Simmons-Menchaca M, Sun L, Sanders BG, Kline K. Vitamin E analog alpha-TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice. Breast Cancer Research and Treatment. 87: 111-21. PMID 15377836 DOI: 10.1023/B:Brea.0000041593.69178.57 |
0.662 |
|
2004 |
Anderson K, Simmons-Menchaca M, Lawson KA, Atkinson J, Sanders BG, Kline K. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA. Cancer Research. 64: 4263-9. PMID 15205340 DOI: 10.1158/0008-5472.Can-03-2327 |
0.638 |
|
2004 |
Lawson KA, Anderson K, Snyder RM, Simmons-Menchaca M, Atkinson J, Sun LZ, Bandyopadhyay A, Knight V, Gilbert BE, Sanders BG, Kline K. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis. Cancer Chemotherapy and Pharmacology. 54: 421-31. PMID 15197487 DOI: 10.1007/S00280-004-0817-Y |
0.718 |
|
2003 |
Kline K, Lawson KA, Yu W, Sanders BG. Vitamin E and breast cancer prevention: current status and future potential. Journal of Mammary Gland Biology and Neoplasia. 8: 91-102. PMID 14587865 DOI: 10.1023/A:1025787422466 |
0.652 |
|
2003 |
Lawson KA, Anderson K, Menchaca M, Atkinson J, Sun L, Knight V, Gilbert BE, Conti C, Sanders BG, Kline K. Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis. Molecular Cancer Therapeutics. 2: 437-44. PMID 12748305 |
0.595 |
|
2003 |
Lawson KA, Anderson K, Menchaca M, Atkinson J, Sun L, Knight V, Gilbert BE, Conti C, Sanders BG, Kline K. Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis Molecular Cancer Therapeutics. 2: 437-444. |
0.571 |
|
Show low-probability matches. |